Norwegian Salmon: Stronger biology pushes out the inflection

Research evidence excerpt

Norwegian Salmon: Stronger biology pushes out the inflection

Barclays | Norwegian Salmon

Strong demand remains supportive, while geopolitical risks have eased: Demand trends

remained constructive through Q1, with management teams across the sector reiterating that

underlying consumption remains healthy across key end markets, particularly Europe and Asia.

Customer engagement remains strong, with producers highlighting continued willingness

among buyers to secure future supply and, in some cases, lock in volumes well into 2027. Export

momentum also remains robust, particularly into Asian markets, supporting confidence that

demand is keeping pace with available supply.

While concerns had emerged around the potential impact of escalating tensions in the Middle

East on consumer confidence, logistics and broader macro sentiment, the recent de-escalation

reduces a key near-term overhang and should provide incremental support to demand.

Combined with a still-favourable consumer preference for healthy protein consumption, this

leaves the demand backdrop broadly supportive for salmon markets.

Salmon relatively more affordable play on the structural protein theme now: We see

salmon equities as an increasingly attractive way to gain exposure to the long-term growth in

global protein consumption. Rising health awareness, increasing protein intake and the

emergence of GLP-1 medications, which are encouraging consumers to prioritise protein-rich

food, continue to support demand for high-quality protein sources. Salmon is particularly well

positioned given its strong nutritional credentials and premium health perception. Importantly,

US salmon prices have moved closer to competing proteins such as beef in recent quarters,

improving relative affordability and supporting consumption.